Investors / Australia / Stoic VC
Stoic VC
Venture capital · Sydney, Australia · Asia Pacific
Stoic VC is a venture firm that invests in science and engineering research originating from Australian research institutions. It partners with founders to turn research into commercially viable products, with cheque sizes ranging from 100k to 1M.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsscienceengineeringresearch commercialisationhuman healthadvanced computingphysical world
Your fit with Stoic VC
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsStoic VC lists 16 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (60%), AI & Machine Learning (20%) and Industrial & Manufacturing (10%). 83% of its companies are based in Australia. It invests most often alongside Uniseed, Brandon BioCatalyst and Brandon Capital.
Counts come from funding rounds that name Stoic VC, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Stoic VC's whole history. Rounds on record name 2 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundStoic VC does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 81th | 12% of companies confirmed by a round |
| Sector focus | 89th | 60% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Uniseed | 10 |
| Brandon BioCatalyst | 5 |
| Brandon Capital | 4 |
| Main Sequence | 2 |
| Startmate | 2 |
| Astanor | 1 |
| Blackbird | 1 |
| Cultiv8 Funds Management | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1594%
- No longer answers00%
- Points to another company16%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 60% | 15% |
| AI & Machine Learning | 20% | 18% |
| Industrial & Manufacturing | 10% | 7% |
| Consumer | 5% | 3% |
| Space & Defense | 5% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Stoic VC head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Stoic VC| Date | Company | Stage |
|---|---|---|
| 17 Dec 2025 | Series A | |
| 22 Oct 2025 | Series B |
Round details for Stoic VC
Amounts, full round histories and every co-investor in Stoic VC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Axelia Oncology develops therapies for cancer patients using the body's immune system. | Healthcare & Biotech | Portfolio page | ||
| BioScout provides airborne crop disease surveillance using AI-powered devices that sample and analyze airborne particulate matter | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Cardihab provides digital cardiac rehabilitation solutions | Healthcare & Biotech | Portfolio page | ||
| Certa Therapeutics develops precision therapies for patients with inflammatory and fibrotic diseases | Healthcare & Biotech | Portfolio page | ||
| ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defense enhancers for the prevention of severe complications from respiratory viral infections in vulnerable populations. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
Healthcare & Biotech | Portfolio page | |||
| Ferronova develops a surgical oncology tracer system to improve treatment guidance and staging of complex cancers | Healthcare & Biotech | Dec 2025Series A | Page + round | |
| Kinoxis Therapeutics develops therapeutics targeting central nervous system indications | Healthcare & Biotech | Portfolio page | ||
| Lenexa Medical develops and sells products for pressure injury prevention and patient monitoring | Healthcare & Biotech | Portfolio page | ||
| Morse Micro develops Wi-Fi HaLow products for long-range wireless connectivity | Industrial & ManufacturingConsumer | Portfolio page | ||
| NatureHelm is a biodiversity intelligence platform that helps businesses understand, manage and report their impact on nature. | AI & Machine LearningSpace & Defense | Portfolio page | ||
| Neurode develops a headband that uses non-invasive brain stimulation to help with focus and productivity | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company produces and sells probiotic drinks. | Healthcare & Biotech | Portfolio page | ||
| Q-Sera develops and manufactures blood collection tubes that rapidly produce high-quality serum for biochemical analysis. | Healthcare & Biotech | Portfolio page | ||
| The company develops novel non-hormonal therapies to address vasomotor symptoms in postmenopausal women and cancer patients. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- stoicvc.com.au
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 22 Oct 2025
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Stoic VC's profile as data
Pull Stoic VC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/stoicvc.com.au
# also
GET /v1/firms/stoicvc.com.au/portfolio
GET /v1/firms/stoicvc.com.au/coinvestors
GET /v1/firms/stoicvc.com.au/news